在患有扩散性大B细胞淋巴瘤的患者中,血清白蛋白水平的预后值

Liyan Chen1, Lili Pan2, Tingbo Liu3

  • 1Department of Breast Surgery, Zhuhai Maternity and Child Health Hospital, Zhuhai, China; Fujian Medical University Union Hospital, Fujian, China.

Acta biochimica Polonica
|December 5, 2023
PubMed
概括

化疗前血清白蛋白 (SA) 水平预测了扩散性大B细胞淋巴瘤 (DLBCL) 患者的结果. 低SA (≤34g/L) 表示预后不佳,存活时间较短,指导临床关注.